we have recently undertaken a multi-centre , randomized , double-blind , placebo-controlled study of regular intravenous immunoglobulin ( ivig ) replacement in patients with cll at risk of infection as defined by presence of hypogammaglobulinaemia , a significant infection history , or both .
C0085297
intravenous
C0023434
cll